Cardiol Therapeutics Inc. Description Of Risk Free Interest Rate Share Options Granted
Cardiol Therapeutics Inc. (CRDL) reported Description Of Risk Free Interest Rate Share Options Granted of 2.72% for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted · last filed 2026-03-31
| Period end | Description Of Risk Free Interest Rate Share Options Granted 12 month |
|---|---|
| 2025-12-31 | 2.72% 40-F · filed 2026-03-31 |
| 2024-12-31 | 3.77% 40-F · filed 2026-03-31 |
| 2023-12-31 | 3.91% 40-F · filed 2025-03-31 |
| 2022-12-31 | 2.44% 20-F · filed 2024-04-01 |
| 2021-12-31 | 0.73% 20-F · filed 2024-04-01 |
| 2020-12-31 | 0.41% 20-F · filed 2023-03-29 |